Brief: Idera Pharmaceuticals Says Ended Q1 With Cash, Cash Equivalents Of $107.5 Mln

Aceragen

16/07/2018 12:12

July 16 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS PROVIDES UPDATE ON CORPORATE
STRATEGY AND
OUTLOOK
    * IDERA PHARMACEUTICALS - ENDED Q1 WITH CASH, CASH
EQUIVALENTS OF
$107.5 MILLION, WHICH AS OF REPORTING OF Q1 ANTICIPATED TO FUND
CURRENT OPERATIONS INTO Q3 2019

Source text for Eikon:  ID:nGNX2b5t4q 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))